Vantage Corp UNDERWRITING AGREEMENTUnderwriting Agreement • June 13th, 2025 • Vantage Corp (Singapore) • Arrangement of transportation of freight & cargo • New York
The undersigned, Vantage Corp, a Cayman Islands holding company (the “Company”), hereby confirms its agreement (this “Agreement”) with several underwriters (such underwriters, including the Representative (as defined below and if there are no underwriters other than the Representative, references to multiple underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as underwriter), the “Underwriters” and each an “Underwriter”) named in Schedule A hereto for which Network 1 Financial Securities, Inc. is acting as the representative to the several Underwriters (in such capacity, the “Representative”) to issue and sell an aggregate of 3,250,000 ordinary shares of the Company (“Firm Shares”), par value $0.001 per share (“Ordinary Shares”). The Company has also granted to the Representative an option to purchase up to 487,500 additional Ordinary Shares, on the terms and for the purposes set forth in Section 2(c) hereof (the “Additional Shares”)
PINNACLE FOOD GROUP LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • April 23rd, 2025 • Pinnacle Food Group LTD • Agricultural services • New York
The undersigned, Pinnacle Food Group Limited, an exempted company incorporated under the laws of the Cayman Islands (the “Company”), hereby confirms its agreement (this “Agreement”) with Craft Capital Management LLC (the “Representative” of several underwriters as disclosed in Schedule A attached hereto, collectively the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of 1,800,000 Class A common shares, par value of US$0.00005 per share (“Class A Common Shares”), of the Company (the “Firm Shares”). The Company also agrees to issue and sell to the Underwriters up to an additional 270,000 Class A Common Shares, representing 15% of the Firm Shares sold in the offering (the “Option Shares”), if and to the extent that the Representative shall have determined to exercise, on behalf of the Underwriters, the right to purchase such Option Shares granted to the Underwriters in Section 1(c) hereof. The Firm Shares and the Option Shares are hereinafter
UNDERWRITING AGREEMENT between AETHER HOLDINGS, INC. and THE BENCHMARK COMPANY, LLCUnderwriting Agreement • April 11th, 2025 • Aether Holdings, Inc. • Services-prepackaged software • New York
The undersigned, Aether Holdings, Inc., a company incorporated under the laws of the State of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with The Benchmark Company, LLC (“Benchmark”) and Axiom Capital Management, Inc. (“Axiom” and together with Benchmark, collectively hereinafter referred to as “you” (including its correlatives) or the “Representatives”, and each, a “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representatives are acting as representatives (each Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
UNDERWRITING AGREEMENTUnderwriting Agreement • April 4th, 2025 • WF International Ltd. • Construction - special trade contractors • New York
The undersigned, WF International Limited, an exempted company incorporated under the laws of the Cayman Islands (the “Company”), hereby confirms its agreement (this “Agreement”) with The Benchmark Company, LLC and Axiom Capital Management, Inc. (each, the “Representative”, and collectively, the “Representatives”) and with the other underwriters, if any, named on Schedule 1 hereto for which the Representatives are acting as Representative (the Representatives and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
MICROPOLIS HOLDING COMPANY UNDERWRITING AGREEMENTUnderwriting Agreement • March 11th, 2025 • Micropolis Holding Co • Motor vehicle parts & accessories • New York
The undersigned, MICROPOLIS HOLDING COMPANY, a Cayman Islands holding company (the “Company”), hereby confirms its agreement (this “Agreement”) with several underwriters (such underwriters, including the Representative (as defined below and if there are no underwriters other than the Representative, references to multiple underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as underwriter), the “Underwriters” and each an “Underwriter”) named in Schedule A hereto for which Network 1 Financial Securities, Inc. is acting as the representative to the several Underwriters (in such capacity, the “Representative”) to issue and sell an aggregate of 3,875,000 ordinary shares of the Company (“Firm Shares”), par value $0.0001 per share (“Ordinary Shares”). The Company has also granted to the Representative an option to purchase up to 581,250 additional Ordinary Shares, on the terms and for the purposes set forth in Section 2(c) hereof (the “Addi
MICROPOLIS HOLDING COMPANY UNDERWRITING AGREEMENTUnderwriting Agreement • February 7th, 2025 • Micropolis Holding Co • Motor vehicle parts & accessories • New York
The undersigned, MICROPOLIS HOLDING COMPANY, a Cayman Islands holding company (the “Company”), hereby confirms its agreement (this “Agreement”) with several underwriters (such underwriters, including the Representative (as defined below and if there are no underwriters other than the Representative, references to multiple underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as underwriter), the “Underwriters” and each an “Underwriter”) named in Schedule A hereto for which Network 1 Financial Securities, Inc. is acting as the representative to the several Underwriters (in such capacity, the “Representative”) to issue and sell an aggregate of [5,000,000] ordinary shares of the Company (“Firm Shares”), par value $0.0001 per share (“Ordinary Shares”). The Company has also granted to the Representative an option to purchase up to [750,000] additional Ordinary Shares, on the terms and for the purposes set forth in Section 2(c) hereof (the “
UNDERWRITING AGREEMENTUnderwriting Agreement • November 7th, 2024 • New York
Schedule 1: List of Underwriters ● Schedule 2-A: Pricing Information ● Schedule 2-B: Issuer General Use Free Writing Prospectuses ● Schedule 2-C: Written Testing-The-Waters Communications ● Schedule 3: Lock-Up Parties ● Exhibit A- Form of Representative's Warrant ● Exhibit B- Lock-Up Agreement for Officers, Directors, and 5% or Greater Shareholders ● Exhibit C- Press Release ● Exhibit D- Opinion and Negative Assurance of Cozen O’Connor ● Exhibit E- Officers' Certificate ● Exhibit F- Secretary's Certificate ●
UNDERWRITING AGREEMENT between ADURO CLEAN TECHNOLOGIES INC. and CRAFT CAPITAL MANAGEMENT LLC AS REPRESENTATIVE OF THE SEVERAL UNDERWRITERSUnderwriting Agreement • November 7th, 2024 • Aduro Clean Technologies Inc. • Chemicals & allied products • New York
The undersigned, Aduro Clean Technologies Inc., a company incorporated under the laws of the Province of British Columbia (the "Company"), hereby confirms its agreement (this "Agreement") with the several underwriters named in Schedule 1 hereto (collectively, the "Underwriters," and each an Underwriter"), for whom Craft Capital Management LLC (hereinafter referred to as "you" (including its correlatives), or "Craft" or the "Representative") is acting as representative, and including EF Hutton LLC ("EF Hutton"), as an underwriter. The Company hereby agrees to issue and sell to the Underwriters an aggregate of 941,177 common shares ("Firm Shares") of the Company, no par value (the "Common Shares"), and, at the election of the Representative, up to an additional 141,176 Common Shares (the "Option Shares" and together with the Firm Shares, the "Shares") in connection with a public offering of the Shares outside of Canada only. The offering and sale of the securities contemplated by this Ag
UNDERWRITING AGREEMENT between ADURO CLEAN TECHNOLOGIES INC. and CRAFT CAPITAL MANAGEMENT LLC AS REPRESENTATIVE OF THE SEVERAL UNDERWRITERSUnderwriting Agreement • September 16th, 2024 • Aduro Clean Technologies Inc. • Chemicals & allied products • New York
The undersigned, Aduro Clean Technologies Inc., a company incorporated under the laws of the Province of British Columbia (the "Company"), hereby confirms its agreement (this "Agreement") with Craft Capital Management LLC (hereinafter referred to as "you" (including its correlatives), or "Craft" or the "Representative") and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the "Underwriters" or, individually, an "Underwriter") for the purchase and sale of an aggregate of [ ] common shares ("Firm Shares") of the Company, no par value (the "Common Shares"), and, at the election of the Representative, up to an additional [ ] Common Shares (the "Option Shares" and together with the Firm Shares, the "Shares") in connection with a public offering of the Shares outside of Canada only. The offering and sale of the securities contemplated by this Agreement is r
UNDERWRITING AGREEMENT between INVIZYNE TECHNOLOGIES, INC. and PUBLIC VENTURES, LLC (D/B/A MDB Capital) INVIZYNE TECHOLOGIES, INC.Underwriting Agreement • August 1st, 2024 • Invizyne Technologies Inc • Biological products, (no disgnostic substances) • New York
The undersigned, Invizyne Technologies, Inc., a corporation formed under the laws of the State of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Invizyne Technologies, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with Public Ventures, LLC (hereinafter referred to as “you” (including its correlatives) or the “Underwriter”) as follows:
UNDERWRITING AGREEMENTUnderwriting Agreement • July 22nd, 2024 • Know Labs, Inc. • Measuring & controlling devices, nec • New York
The undersigned, Know Labs, Inc., a Nevada corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with Boustead Securities, LLC and The Benchmark Company LLC (hereinafter referred to as “you” (including its correlatives) or the “Representatives”) and with the other underwriters named on Schedule 1 hereto for which the Representatives are acting as representatives (the Representatives and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
Underwriting AgreementUnderwriting Agreement • April 18th, 2024 • Serve Robotics Inc. /DE/ • Miscellaneous transportation equipment • New York
Underwriting AgreementUnderwriting Agreement • April 12th, 2024 • Serve Robotics Inc. /DE/ • Miscellaneous transportation equipment • New York
UNDERWRITING AGREEMENT between LIRUM THERAPEUTICS, INC. and THINKEQUITY LLC as Representative of the Several Underwriters LIRUM THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 22nd, 2024 • Lirum Therapeutics, Inc. • Pharmaceutical preparations • New York
The undersigned, Lirum Therapeutics, Inc., a corporation formed under the laws of the State of Delaware (collectively with its affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being an affiliate of Lirum Therapeutics, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as set forth below.
UNDERWRITING AGREEMENT between LIRUM THERAPEUTICS, INC. and THINKEQUITY LLC as Representative of the Several Underwriters LIRUM THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 11th, 2024 • Lirum Therapeutics, Inc. • Pharmaceutical preparations • New York
The undersigned, Lirum Therapeutics, Inc., a corporation formed under the laws of the State of Delaware (collectively with its affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being an affiliate of Lirum Therapeutics, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as set forth below.
UNDERWRITING AGREEMENT between LIRUM THERAPEUTICS, INC. and THINKEQUITY LLC as Representative of the Several Underwriters LIRUM THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 2nd, 2024 • Lirum Therapeutics, Inc. • Pharmaceutical preparations • New York
The undersigned, Lirum Therapeutics, Inc., a corporation formed under the laws of the State of Delaware (collectively with its affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being an affiliate of Lirum Therapeutics, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as set forth below.
UNDERWRITING AGREEMENT between ALTA GLOBAL GROUP LIMITED and THINKEQUITY LLC as Representative of the Several Underwriters ALTA GLOBAL GROUP LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • December 22nd, 2023 • Alta Global Group LTD • Services-miscellaneous business services • New York
The undersigned, Alta Global Group Limited, an Australian public company limited by shares (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Alta Global Group Limited, the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC, (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
BIOLINGUS (CAYMAN) LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • December 19th, 2023 • BioLingus (Cayman) LTD • Pharmaceutical preparations • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • November 30th, 2023 • RoyaLand Co Ltd. • Services-prepackaged software • New York
The undersigned, The RoyaLand Company Ltd., an exempted company incorporated in Bermuda with limited liability (the “Company”), hereby confirms its agreement (this “Agreement”) with Revere Securities, LLC together with its subsidiaries and affiliates (collectively “Revere,” hereinafter referred to as “you” or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
BIOLINGUS (CAYMAN) LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • November 9th, 2023 • BioLingus (Cayman) LTD • Pharmaceutical preparations • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • November 8th, 2023 • WF International Ltd. • Construction - special trade contractors • New York
The undersigned, WF International Limited, an exempted company incorporated under the laws of the Cayman Islands (the “Company”), hereby confirms its agreement (this “Agreement”) with The Benchmark Company, LLC and Axiom Capital Management, Inc. (each, the “Representative”, and collectively, the “Representatives”) and with the other underwriters, if any, named on Schedule 1 hereto for which the Representatives are acting as Representative (the Representatives and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
UNDERWRITING AGREEMENT between Rise Oil & Gas, Inc. and THINKEQUITY LLC as Representative of the Several Underwriters Rise Oil & Gas, Inc.Underwriting Agreement • July 3rd, 2023 • Rise Oil & Gas, Inc. • Crude petroleum & natural gas • New York
The undersigned, Rise Oil & Gas, Inc., a corporation formed under the laws of the State of Nevada (the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters, if any, named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
UNDERWRITING AGREEMENTUnderwriting Agreement • June 30th, 2023 • RoyaLand Co Ltd. • Services-prepackaged software • New York
The undersigned, The RoyaLand Company Ltd., an exempted company incorporated in Bermuda with limited liability (the “Company”), hereby confirms its agreement (this “Agreement”) with Revere Securities, LLC together with its subsidiaries and affiliates (collectively “Revere,” hereinafter referred to as “you” or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
BIOLINGUS (CAYMAN) LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • June 30th, 2023 • BioLingus (Cayman) LTD • Pharmaceutical preparations • New York
UNDERWRITING AGREEMENT between MAIA BIOTECHNOLOGY, INC. and THINKEQUITY LLC as Representative of the Several Underwriters MAIA BIOTECHNOLOGY, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • June 8th, 2023 • MAIA Biotechnology, Inc. • Pharmaceutical preparations • New York
The undersigned, MAIA Biotechnology, Inc., a corporation formed under the laws of the State of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”). To the extent there are no additional underwriters named in Schedule I hereto other than you, the term Representative as used herein shall mean you, as Underwriter, and the terms “Representative” and “Underwriter” shall mean either the singular or the plural as the context requires.
UNDERWRITING AGREEMENT between FOREMOST LITHIUM RESOURCE & TECHNOLOGY LTD. and THINKEQUITY LLC as Representative of the Several Underwriters FOREMOST LITHIUM RESOURCE & TECHNOLOGY LTD.Underwriting Agreement • May 18th, 2023 • Foremost Lithium Resources & Technology Ltd. • Miscellaneous metal ores • New York
ThinkEquity LLC As Representative of the several Underwriters named on Schedule 1 attached hereto 17 State Street, 41st Floor
SOCIETY PASS INCORPORATED UNDERWRITING AGREEMENTUnderwriting Agreement • October 13th, 2021 • Society Pass Incorporated. • Services-business services, nec • New York
The undersigned, Society Pass Incorporated, a Nevada corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), (A) an aggregate of __________ shares of common stock, (the “Firm Shares”) par value $0.0001 per share of the Company (“Common Stock”) and (B) at the election of the Representative, up to an additional _______ shares of Common Stock (the “Option Shares”, and together with the Firm Shares, the “Shares”). The offering and sale of the Shares contemplated by this Agreement is referred to herein as the “Offering”.
CHINA RECYCLING ENERGY CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • October 7th, 2021 • China Recycling Energy Corp • Services-business services, nec • New York
UNDERWRITING AGREEMENT between Context Therapeutics Inc. and THINKEQUITY A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC. as Representative of the Several UnderwritersUnderwriting Agreement • July 2nd, 2021 • Context Therapeutics Inc. • Pharmaceutical preparations • New York
The undersigned, Context Therapeutics Inc., a corporation formed under the laws of the State of Delaware (, the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity, a division of Fordham Financial Management, Inc., (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
UNDERWRITING AGREEMENTUnderwriting Agreement • April 27th, 2021 • Focus Universal Inc. • Industrial instruments for measurement, display, and control • New York
The undersigned, Focus Universal Inc., a Nevada corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with Boustead Securities, LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters, if any, named on Schedule 1 hereto, for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
UNDERWRITING AGREEMENT between HEPION PHARMACEUTICALS INC. and THINKEQUITY, A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC., as Representative of the Several Underwriters HEPION PHARMACEUTICALS INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 17th, 2021 • Hepion Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
The undersigned, Hepion Pharmaceuticals Inc., a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Hepion Pharmaceuticals Inc. (the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity, a division of Fordham Financial Management, Inc. (hereinafter referred to as “you” (including its correlatives) or the “Representative”), and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the “Representative” and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
UNDERWRITING AGREEMENT between VALLON PHARMACEUTICALS, INC. and THINKEQUITY A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC. as Representative of the Several Underwriters VALLON PHARMACEUTICALS, INC.Underwriting Agreement • February 16th, 2021 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
The undersigned, Vallon Pharmaceuticals, Inc., a corporation formed under the laws of the State of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity, a division of Fordham Financial Management, Inc., (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
NLS PHARMACEUTICS LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • January 20th, 2021 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations • New York
The undersigned, NLS Pharmaceutics Ltd., a corporation incorporated under the laws of Switzerland (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), an aggregate of ________ units (the “Firm Units” or “Units”) of the Company’s securities, and, at the election of the Representative, up to an additional ________ Option Shares (as defined herein and collectively with the Common Shares (as defined below) underlying the Firm Units, the “Shares”), and/or up to an additional _________ Option Warrants (as defined herein and collectively with warrants underlying the Firm Units, the “Warrants”). Each Unit consists of one Common Share (the “Firm Shares”) of the Company, par value CHF 0.02 per share (the “Common Shares”) and on
UNDERWRITING AGREEMENT between VISION MARINE TECHNOLOGIES INC. and THINKEQUITY A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC. as Representative of the Several Underwriters VISION MARINE TECHNOLOGIES INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 30th, 2020 • Vision Marine Technologies Inc. • Ship & boat building & repairing • New York
The undersigned, Vision Marine Technologies Inc. (d/b/a Canadian Electric Boat Company), a corporation formed under the laws of Québec, Canada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Vision Marine Technologies Inc. (d/b/a Canadian Electric Boat Company), the “Company”), hereby confirms and enters into this agreement (this “Agreement”) with ThinkEquity, a division of Fordham Financial Management, Inc., (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
NLS PHARMACEUTICS LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • November 13th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations • New York
The undersigned, NLS Pharmaceutics Ltd., a corporation incorporated under the laws of Switzerland (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), an aggregate of ________ units (the “Firm Units” or “Units”) of the Company’s securities, and, at the election of the Representative, up to an additional ________ Option Shares (as defined herein and collectively with the Common Shares (as defined below) underlying the Firm Units, the “Shares”), and/or up to an additional _________ Option Warrants (as defined herein and collectively with warrants underlying the Firm Units, the “Warrants”). Each Unit consists of one Common Share (the “Firm Shares”) of the Company, par value CHF 0.02 per share (the “Common Shares”) and on